Samantha Pearce Jazz Pharmaceuticals PLC (JAZZ) insider trading activity
Samantha Pearce is EVP, Chief Commercial Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 41,226 shares of JAZZ, which is worth approximately $4.4 Million. The most recent transaction as insider was on Jun 27, 2022, when has been sold 8,508 shares (Ordinary Shares) at a price of $155.0 per share, resulting in proceeds of $1,318,740. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
41.2K
0%
3M change
143.62%
12M change
Total Value Held
$4.4 Million
Samantha Pearce Transaction History
SP
Samantha Pearce
EVP, Chief Commercial Officer
Dublin 4, L2